Introduction
============

Schizophrenia (SZ, Online Mendelian Inheritance in Man \[OMIM\] 181500) is a common and serious psychiatric disorder with a lifetime prevalence estimate of 4.0 (1.6--12.1) per 1,000 individuals ([@B9]). SZ has been reported to be a predominantly genetic disorder, in which heritability is estimated to be 80% ([@B26]).

The human *RELN* gene (OMIM 600514) maps to chromosome 7q22 and encodes reelin, a large secreted glycoprotein, that is thought to be critical for cell positioning and neuronal migration by controlling cell-cell interactions during brain development ([@B14]; [@B17]; [@B32]). Recently, growing evidence has shown that the reelin protein might also be associated with neurotransmission, memory formation and synaptic plasticity ([@B15]), which have been demonstrated to also be damaged in SZ patients ([@B10]). Decrease trends in reelin expression in patients with SZ have been found in brain and blood tissues ([@B19]; [@B13]; [@B30]). Hence, low level or dysfunctional of reelin protein may cause deficits in neuronal development and cognitive function in adults and may play pathogenic roles in neuropsychiatric illnesses, such as SZ. This proposition was further supported by anatomical and *in vivo* studies that included the reeler mice and the heterozygous reeler mouse (HRM) model ([@B16]; [@B35]; [@B42]). The role of *RELN* as a potential risk for SZ has also been suggested by genetic association analysis, especially in GWASs ([@B37]; [@B25], [@B24]; [@B34]; [@B51]). Over the past decade, dozens of SNPs in *RELN* gene loci have been reported to be associated with the onset and/or severity of clinical symptoms of SZ ([@B20]; [@B37]; [@B44], [@B45]; [@B31]; [@B4]; [@B27]; [@B22]; [@B24]). However, the results remain controversial ([@B41]; [@B24]; [@B5]).

In this study, we assumed that RELN may be related to the onset of SZ and the severity of some clinical symptoms. A case--control study had been performed in the Han Chinese population from southern China. To thoroughly understand the genetic basis of mental symptoms in SZ rather than only focus on verifying previous positive results and searching for new susceptible SNPs in *RELN*, we specifically performed quantitative trait locus (QTL) analyses in addition to qualitative association studies. Due to the high clinical and genetic heterogeneity of SZ, different clinical subtypes of SZ may be related to different genetic bases, we specifically collected patients with paranoid or undifferentiated SZ who experienced first onset or recurrence after drug withdrawal at least 1 month to improve the consistency of research subjects and to minimize the influence of drug on the scores of PANSS.

Materials and Methods {#s1}
=====================

Subjects
--------

The patient sample consisted of 102 unrelated SZ patients (46 females and 56 males; mean age, 32.42 ± 10.08 years) recruited from the Third People's Hospital of Zhongshan City during 2012.11--2013.06. Patients were diagnosed by at least two psychiatrists according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, DSM-IV). Detailed information on clinical features, such as the onset time, symptoms and family history of mental illness, were obtained according to DIGS and FIGS. The PANSS was used to evaluate the severity of psychosis symptoms of SZ patients. It is one of the most common instruments applied to evaluate the severity of clinical symptoms in the world ([@B21]). PANSS comprises 33 items, including 30 psychopathological items which are usually divided into the positive subscale (7 items), the negative subscale (7 items) and the general psychopathology subscale (16 items) and 3 complementary attack risk items. The item level of the 33 items ranges from 1 to 7, with 1 equaling "no symptoms" ([@B21]). The Chinese version of PANSS, with acceptable validity and reliability, was used to evaluate the severity of psychosis symptoms of SZ patients in this study ([@B38]). Paranoid or undifferentiated SZ patients who were at first onset, having never been treated, or at recurrence, having not taken any antipsychotics for at least 1 month, were enrolled in. Among them, patients with the both-negative type (i.e., the number of items with a score greater than or equal to 4 was less than three on both positive and negative subscales in PANSS) were excluded. All patients with ambiguous diagnoses or accompanied by neurological diseases, organic mental disorders or other symptomatic psychoses, or who had concomitant severe somatic disease, cancer, pregnancy or lactation, an immune or endocrine system disease, or a history of alcoholism or substance abuse were excluded.

A total of 169 healthy controls (75 females and 94 males; mean age 33.27 ± 8.63 years) matched with the patients in sex, age, and birthplace at the same time were randomly recruited from the volunteers who came to perform physical examination in the Affiliated Hospital of Sun Yat-sen University during 2013.06--2013.11. Volunteers were asked to provide detailed information on medical and family psychiatric histories. Subjects were excluded due to any of the following: positive family histories (first-degree relatives) of psychiatric illness; substance abuse; abnormal birth; febrile convulsions; juvenile adoption or residence with a single-parent family; pregnancy or lactation.

All participants were unrelated Han Chinese born and living in the southern China (mostly come from Guangdong province and nearby cities), and all their biological grandparents were Han Chinese ancestry. They provided written informed consent for participation, and the research protocol was approved by the Ethical Committee for Genetic Studies of Shantou University.

SNP Selection
-------------

The SNPs were based on previous studies ([@B36]; [@B7]; [@B46]) and/or screened by SNP functional prediction softwares, including SIFT ([@B23]), PolyPhen-2 ([@B1]), and FASTSNP ([@B49]). Information on the SNPs was obtained from dbSNP, HapMap and other human genome databases. A SNP would be approved only when its MAF was greater than or equal to 0.01 in the Chinese Beijing population in the HapMap database. The detailed strategies for SNP selection were as follows. (1) "Positive" SNPs that have been reported to be associated with SZ previously were selected once their MAFs were greater than or equal to 0.01 in the Chinese Beijing population in the HapMap database. (2) A two-step method was executed for the selection of exonic SNPs ([Figure 1A](#F1){ref-type="fig"}). First, PolyPhen-2, the SIFT online service and the FASTSNP online service were employed for functional analysis of exonic SNPs. Next, by comparing the outputs of the three software programs, repeated SNPs with MAFs equal to or greater than 0.01 were chosen. (3) For intronic SNPs, a four-step method was conducted using the FASTSNP, SNP functional prediction ([@B47]), F-SNP online services and HapMap database successively, and SNPs with MAFs greater than or equal to 0.05 were preserved ([Figure 1B](#F1){ref-type="fig"}). (4) By using FASTSNP, UTRscan ([@B36]), and UCSC Variant Annotation Integrator online software ([@B29]), similar functional analyses of exonic SNPs were conducted among UTR and upstream SNPs of *RELN*, but a higher MAF threshold of 0.05 was implemented. Rs7341475, a "positive" SNP thought to be associated with SZ ([@B37]; [@B4]) was not included in this study, as there was no significant evidence implying that rs7341475 may associate with SZ in the Han Chinese population ([@B25], [@B24]).

![The general screening flows of exonic **(A)** and intronic **(B)** SNPs in the SNP selection phase.](fgene-10-00175-g001){#F1}

SNP Genotyping
--------------

For each participant, 5 ml peripheral venous blood was collected after signing informed consent and before drug used. Genomic DNA was extracted using the phenol-chloroform method within 1--2 weeks and saved in −20°C refrigerator. SNP genotyping was performed with the Sequenom MassARRAY iPLEX Gold platform (Sequenom, San Diego, CA, United States) ([@B18]). Primers were designed using the MassARRAY Assay Design 3.1 software. Two amplification primer systems were built with the balance of capturing as many SNP loci as possible while limiting costs. Genomic fragments containing SNPs were amplified by polymerase chain reaction (PCR) in a total reaction volume of 5 μl, which included 20--50 ng of genomic DNA, in two 384-well plates using the ABI GeneAmp^®^ 9700 384 Dual. Purified and specific genotyping primers were used to amplify target sites. Genotypes were automatically called by MassARRAY Typer 4.0 and verified manually. To ensure the accuracy of genotyping, 32 samples were duplicated for quality control, and no genotyping errors were found. Additionally, each 384-well plate had four blank controls. Any individual whose missing genotypes were greater than 50% was excluded from further statistical analysis.

Statistical Analysis
--------------------

Statistical analyses including HWE, the description of MAF, single marker association of allele, the standardized measure of linkage disequilibrium (LD) coefficients (D'), haplotype block and haplotype frequency and association within the block were all assessed using Haploview v4.2 software (version 4.2, Broad Institute of MIT and Harvard, Cambridge, MA, United States) ([@B12]; [@B2]). The haplotype frequency was estimated using the expectation maximization (EM) algorithm. The criterion for significances in Haploview v4.2 was set at p smaller than 0.05 for tests of expected HWE and corrected *p*-value after 10000 permutations.

The SPSS 19.0 were used to analyzing the demographic and genotypic frequency distribution of samples using *t*-tests or chi-square tests. Logistic regression analyses of population, sex, and age were used to generate population stratification assignments for all individuals. The criterion for significance in SPSS 19.0 was set at p smaller than 0.05. Genotype and multiple SNPs qualitative traits association tests between patients and controls were performed with Unphased 3.1.7 ([@B8]). The overall test of association in Unphased 3.1.7 is a likelihood ratio test. And the odds ratio (OR) and 95% confidence interval (95% CI) were calculated automatically to evaluate the effects of alleles and haplotypes. To further investigate the possibility of complexity in the genotype-phenotype relationship, QTL analyses were also performed with Unphased v3.1.7 using 33 factor scores and 4 scale scores (i.e., the total scale score, the positive scale score, the negative scale score, and the general psychopathology scale score) from PANSS as quantitative traits. In QTL analyses, the addVal (i.e., additive genetic value) instead of OR was calculated automatically to show the estimated additive genetic value for special haplotype. For all multiple tests performed in Unphased 3.1.7, Bonferroni correction and FDR correction were employed to correct *p*-values and minimize the influence of type II errors. The corrected *p*-value threshold of 0.05 was used for significant after Bonferroni correction (*p*~Bonf~ = α × m, α is the desired overall alpha level of 0.05, and m is the number of hypotheses) and FDR correction (the corrected *p*-value was shown as *p*~FDR~) which was performed using R projection Version 3.1.2^[1](#fn01){ref-type="fn"}^. A power analysis was performed using the G^∗^Power software for this study ([@B11]).

Results
=======

SNP Selection and Genotyping
----------------------------

Initially, thirty-nine SNPs were screened, including twenty-nine "positive" SNPs reported previously and ten "functional" SNPs, from more than ten thousand *RELN* loci. Screening flows and the number of targeted SNPs in exonic and intronic zones in the *RELN* gene are shown in [Figure 1](#F1){ref-type="fig"}. Six SNPs (i.e., rs362746, rs12705169, rs885995, rs11761011, rs16872603, and rs2237628) were ruled out for poor specificity or missing data, and three SNPs (i.e., rs3025962, rs73714410, and rs7811571) were monomorphic in the samples. Therefore, 30 SNPs in the *RELN* gene were genotyped successfully in 100 SZ patients (45 females and 55 males; mean age, 32.170 ± 10.000 years) and 163 healthy controls (74 females and 89 males; mean age, 33.350 ± 8.585 years). No differences were found between patients and controls in age (*t* = 1.015, *df* = 261, *p* = 0.311) and gender (χ^2^ = 0.004, *df* = 1, *p* = 1.000). The average call rate of all SNPs was 99.5% in total sample. No SNP deviation from HWE was found in the controls ([Table 1](#T1){ref-type="table"}). Among 30 SNPs, there are 2 exonic SNPs and 28 intronic SNPs. The rough distribution of the 30 SNPs is shown in [Figure 2](#F2){ref-type="fig"}.

###### 

Genotype frequencies, HWE tests, and single-SNP association analyses of 30 RELN SNPs in the SZ and control cases.

  dbSNP ID       Allele (D/d)^a^   Case   Control   Genotype (*p*)^e^   Allele (*P*)^e^                                                              
  -------------- ----------------- ------ --------- ------------------- ----------------- ---- ------- ----- ------- ----- ---- ---- ------- ------- -------
  rs11764507     G/A               100    0.068     72                  22                6    0.170   161   0.381   106   52   3    0.180   0.062   0.768
  rs17157643     T/A               100    1.000     78                  21                1    0.115   162   0.734   137   25   0    0.077   0.213   0.145
  rs6465938      C/T               100    0.046     40                  38                22   0.410   163   0.388   60    83   20   0.377   0.048   0.455
  rs39339        A/C               100    0.416     77                  20                3    0.130   162   0.714   126   35   1    0.114   0.283   0.589
  rs155333       G/A               100    0.123     54                  34                12   0.290   162   0.546   78    72   12   0.296   0.201   0.878
  rs262355       T/A               99     0.071     55                  32                12   0.283   162   0.700   80    70   12   0.290   0.173   0.858
  rs1510846      T/C               95     0.834     29                  49                17   0.437   162   0.210   50    72   40   0.469   0.408   0.478
  rs11496125     C/T               98     1.000     36                  47                15   0.393   162   0.447   65    71   26   0.380   0.850   0.764
  rs10435342     C/T               100    0.277     85                  13                2    0.085   163   0.995   143   19   1    0.064   0.599   0.376
  rs661575       C/T               99     0.131     51                  34                14   0.308   163   0.072   81    60   22   0.319   0.958   0.794
  rs607755       A/G               99     1.000     37                  47                15   0.389   160   0.182   47    88   25   0.431   0.429   0.342
  rs563264       A/G               100    1.000     95                  5                 0    0.025   162   0.443   150   11   1    0.040   0.386   0.356
  rs540058       T/C               98     1.000     93                  5                 0    0.026   161   0.446   149   11   1    0.040   0.404   0.370
  rs727708       A/G               100    0.943     30                  51                19   0.445   160   1.000   36    80   44   0.475   0.184   0.076
  rs12705141     A/T               100    0.664     74                  23                3    0.145   161   0.747   110   45   6    0.177   0.528   0.338
  rs2299356      A/G               100    0.406     34                  53                13   0.395   161   0.880   47    82   32   0.453   0.344   0.190
  rs362691^f^    G/C               100    1.000     84                  15                1    0.085   163   1.000   121   39   3    0.138   0.153   0.067
  rs123714       C/T               100    0.763     52                  40                10   0.300   163   0.614   91    64   8    0.245   0.247   0.169
  rs123713       C/T               100    0.763     50                  40                10   0.300   161   0.899   90    62   9    0.248   0.339   0.196
  rs144525       A/G               99     0.536     69                  29                1    0.157   161   0.380   101   56   4    0.199   0.448   0.227
  rs362626       C/A               100    1.000     40                  46                14   0.370   161   0.307   61    82   18   0.366   0.628   0.935
  rs362814       A/T               99     0.613     41                  43                15   0.369   161   0.497   62    80   19   0.366   0.521   0.959
  rs362813       T/C               100    0.961     26                  49                25   0.495   163   0.694   47    78   38   0.472   0.857   0.614
  rs362731       T/C               100    1.000     26                  50                24   0.490   162   0.759   47    78   37   0.469   0.856   0.642
  rs362726       T/C               98     0.879     24                  51                23   0.495   163   1.000   56    79   28   0.414   0.189   0.072
  rs2535764      C/T               99     0.066     68                  24                7    0.192   163   0.352   106   48   9    0.202   0.647   0.769
  rs362719       C/A               100    0.926     36                  47                17   0.405   159   0.131   74    62   23   0.340   0.258   0.132
  rs2299334      G/A               100    0.680     66                  32                2    0.180   163   1.000   104   52   7    0.202   0.612   0.527
  rs11976900     A/G               99     0.486     57                  34                8    0.253   161   0.139   92    54   15   0.261   0.951   0.833
  rs2229864^f^   C/T               100    1.000     68                  29                3    0.175   161   0.214   104   47   10   0.208   0.545   0.354

a

Major/minor allele, major, and minor alleles are denoted by D and d, respectively.

b

Numbers of samples that are successfully genotyped in patients and controls, respectively.

c

p-Values of the Hardy-Weinberg equilibrium (HWE) tests from Haploview v4.2.

d

The minor allele frequency of 30 selected SNPs in this study.

e

Uncorrected p-values of allelic and genotypic association analysis in this study.

f

Two exonic SNPs selected in this report.

![The genomic structure of *RELN* and the physical locations of the 30 tested SNPs. Among them, rs362691 and rs2229864 are located in the exonic areas (vertical bars), and the others are located in the intronic areas (spaces).](fgene-10-00175-g002){#F2}

Single-SNP Association Analyses
-------------------------------

Detailed information regarding the allelic and genotypic frequencies of the 30 SNPs from patients and controls was obtained ([Table 1](#T1){ref-type="table"}). No single polymorphism was found to be significantly associated with SZ neither in the total sample ([Table 1](#T1){ref-type="table"}) nor when grouped by sex ([Table 2](#T2){ref-type="table"}). The weak genotypic association of rs6465938 (χ^2^ = 6.087, *df* = 2, *p* = 0.048) did not withstand the FDR correction (*p*~FDR~ = 0.713).

###### 

The sex differences in single-SNP association analyses of 30 RELN SNPs in SZ and control cases.

  SNPs IDs     Allele   Genotype                                                               
  ------------ -------- ---------- ------- ------- --- ------- ------- --- ------- ------- --- -------
  rs10435342   0.182    1          0.67    0.347   1   0.556   0.564   2   0.754   0.297   2   0.862
  rs11496125   0.109    1          0.741   0.023   1   0.88    0.157   2   0.925   0.357   2   0.836
  rs11764507   0.029    1          0.864   0.017   1   0.896   2.351   2   0.309   3.808   2   0.149
  rs11976900   0.083    1          0.773   0.006   1   0.936   0.074   2   0.964   0.236   2   0.889
  rs123713     2.082    1          0.149   0.128   1   0.721   2.956   2   0.228   4.129   2   0.127
  rs123714     2.514    1          0.113   0.128   1   0.721   2.864   2   0.239   4.129   2   0.127
  rs12705141   0.128    1          0.72    2.408   1   0.121   0.368   2   0.832   2.158   2   0.34
  rs144525     0.38     1          0.538   0.873   1   0.35    2.941   2   0.23    1.585   2   0.453
  rs1510846    1.12     1          0.29    0.056   1   0.813   1.247   2   0.536   2.278   2   0.32
  rs155333     0.039    1          0.844   0.002   1   0.967   3.367   2   0.186   0.485   2   0.785
  rs17157643   2.829    1          0.093   0.111   1   0.739   3.603   2   0.165   0.127   1   0.721
  rs2229864    0.004    1          0.951   1.338   1   0.247   0.561   2   0.755   2.543   2   0.28
  rs2299334    0.645    1          0.422   0.013   1   0.91    1.073   2   0.585   0.077   2   0.962
  rs2299356    0.123    1          0.725   2.312   1   0.128   0.626   2   0.731   5.617   2   0.06
  rs2535764    0.8      1          0.371   0.079   1   0.779   3.573   2   0.168   0.295   2   0.863
  rs262355     0.1      1          0.752   0.025   1   0.874   4.161   2   0.125   0.367   2   0.832
  rs362626     0.465    1          0.495   0.142   1   0.706   0.667   2   0.716   4.031   2   0.133
  rs362691     1.339    1          0.247   2.304   1   0.129   1.903   2   0.386   2.812   2   0.245
  rs362719     0.728    1          0.393   0.986   1   0.321   1.571   2   0.456   1.025   2   0.599
  rs362726     1.641    1          0.2     1.01    1   0.315   3.042   2   0.219   1.534   2   0.464
  rs362731     0.834    1          0.361   0.141   1   0.707   2.87    2   0.238   1.35    2   0.509
  rs362813     0.955    1          0.329   0.141   1   0.707   2.541   2   0.281   1.35    2   0.509
  rs362814     0.094    1          0.759   0       1   0.997   0.197   2   0.906   4.083   2   0.13
  rs39339      0.915    1          0.339   0.19    1   0.663   1.342   2   0.511   2.89    2   0.236
  rs540058     2.504    1          0.114   0.253   1   0.615   2.722   2   0.256   0.258   1   0.612
  rs563264     2.682    1          0.102   0.256   1   0.613   2.871   2   0.238   0.26    1   0.61
  rs607755     0.314    1          0.575   0.542   1   0.462   1.12    2   0.571   0.756   2   0.685
  rs6465938    0.367    1          0.545   0.193   1   0.66    3.56    2   0.169   3.38    2   0.184
  rs661575     2.413    1          0.12    3.339   1   0.068   2.166   2   0.338   3.058   2   0.217
  rs727708     0.636    1          0.425   3.321   1   0.068   1.458   2   0.482   4.565   2   0.102

Haplotype Association Analyses
------------------------------

Five blocks were captured using Haploview v4.2 software in the total sample ([Figure 3](#F3){ref-type="fig"}). The frequency and haplotype association within the block were shown in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. No haplotype analysis within the block survived before 10000 permutations. Haplotype associations of 2-SNP, 3-SNP, and 4-SNP were analyzed using Unphased v3.1.7 software. When performing logistic regression analyses, only birthplace shown the population stratification \[*p* = 0.019, Exp (B) = 0.526, 95% CI 0.308--0.898\]. To reduce the stratification, we employed birthplace, sex, and age as covariates in the association analyses. Two 3-SNP haplotype blocks (one consisting of rs362814, rs39339, and rs540058, and the other consisting of rs362691, rs362719, and rs362726) were identified before multiple adjustment (χ^2^ = 19.406, *df* = 6, *p* = 0.004, *p*~Bonf~ = 0.099 and χ^2^ = 20.621, *df* = 7, *p* = 0.004, *p*~Bonf~ = 0.122, respectively). The haplotype with four SNPs (rs362814, rs39339, rs540058, and rs661575) was significantly associated with SZ (χ^2^ = 29.024, *df* = 9, *p* = 6.42E-04), even after Bonferroni and FDR correction (both *p*~adjustment~ = 0.017). And the T-C-T-C haplotype of the four SNPs was more common in the controls (0.764% in case versus 6.173% in controls, OR = 0.050, 95% CI = 0.004--0.705). No sex effect was found in multiple SNP analyses (date not shown).

![Linkage disequilibrium (LD) among the 30 RELN SNPs in the case and control groups. The pairwise LD *R*^2^ values of the sample set are illustrated in the matrix. The dark color indicates relatively strong LD. The *R*^2^ values of five blocks covering the *RELN* gene were larger than 0.75, indicating reasonable haplotype blocks.](fgene-10-00175-g003){#F3}

QTL Association Analyses
------------------------

For the QTL analyses, we used smoking, birthplace, age, and sex as covariates, as smoking may be associated with the severity of the negative symptoms ([@B50]). Several factors rather than scale score were significantly associated with 3-SNP or 4-SNP haplotypes after FDR correction ([Table 3](#T3){ref-type="table"}, more information shown in [Supplementary Table S2](#SM2){ref-type="supplementary-material"}). The T-C-T haplotype and C-T-T haplotype of the 3-SNP consisting of rs2229864, rs2535764 and rs262355 were related to the severity of P7 (hostility) (AddVal = 0.748, 95% CI = 0.291--1.204 and AddVal = 0.718, 95% CI = 0.230--1.206). No significant result was found in SNP or 2-SNP QTL association analyses neither in total sample nor grouped by sex (data not shown). We did not performed 3-SNP and 4-SNP QTL association analyses in male or female patients due to the small sample.

###### 

Positive results of haplotype QTL association analyses.

  PANSS item   SNP1 ID      SNP2 ID      SNP3 ID      SNP4 ID      χ^2^     df   *p*        *p*~Bonf~   *p*~FDR~
  ------------ ------------ ------------ ------------ ------------ -------- ---- ---------- ----------- ----------
  P7           rs2229864    rs2535764    rs262355                  31.424   6    2.10E-05   0.019       0.019
  G11          rs12705141   rs144525     rs1510846    rs2299334    36.900   10   5.89E-05   0.052       0.025
  G16          rs362814     rs39339      rs540058     rs661575     28.620   7    1.70E-04   0.151       0.025
  P7           rs2229864    rs2535764    rs262355     rs362626     37.772   12   1.67E-04   0.149       0.025
  G14          rs2229864    rs2535764    rs262355     rs362626     36.621   12   2.57E-04   0.229       0.026
  S3           rs2229864    rs2535764    rs262355     rs362626     33.360   11   4.60E-04   0.41        0.041
  P7           rs17157643   rs2229864    rs2535764    rs262355     32.060   8    9.09E-05   0.081       0.025
  S3           rs17157643   rs2229864    rs2535764    rs262355     29.611   8    2.48E-04   0.221       0.026
  G14          rs10435342   rs11496125   rs11764507   rs11976900   33.280   9    1.19E-04   0.106       0.025
  P4           rs10435342   rs11496125   rs11764507   rs11976900   25.774   7    5.53E-04   0.493       0.045
  P7           rs155333     rs17157643   rs2229864    rs2535764    30.959   8    1.43E-04   0.127       0.025
  S3           rs155333     rs17157643   rs2229864    rs2535764    29.445   8    2.65E-04   0.236       0.026

P4: excitement; P7: hostility; G11: poor attention; G14: Poor impulse control; G16: active social avoidance; S3: emotional instability; p

Bonf

: corrected p-values by Bonferroni correction; p

FDR

: corrected p-values by FDR correction.

Power
-----

The G^∗^Power program was used to perform the power calculation. The size of this sample revealed a power of 98.873% to detect a significant association (α \< 0.05) when given an effect size index of 0.5 (corresponding to a "medium" gene effect). However, the power narrowed down to 47.033% when the effect size index was 0.2 (corresponding to a "small" gene effect).

Discussion
==========

Schizophrenia is a complex genetic disease with diverse clinical symptoms. Here, we performed qualitative and quantitative trait association analyses in a Han Chinese population from southern China to verify that *RELN* was a susceptibility gene for SZ. The results of multiple SNP analyses confirmed the genotype-phenotype relationship between *RELN* and SZ.

A 4-SNP haplotype consisting of rs362814, rs39339, rs540058, and rs661575 was observed to be significantly associated with SZ even after the Bonferroni correction, and the T-C-T-C haplotype may be a protective factor for SZ. Moreover, when performing QTL analysis, this 4-SNP haplotype had a significant association with G16 after FDR correction. These results suggested the importance of the four SNPs, which was supported by previous studies. A study of Han population origin from southwestern China demonstrated that the allele of rs362814 was more common in SZ cases and the A and T alleles took part in the building of a risk haplotype and a protective haplotype, respectively ([@B24]). In our study, the T allele of rs362814 also took part in building a protective haplotype in the participants, but with different SNPs. Rs39339 was slightly significant in allelic association tests before the Bonferroni correction and nominally significant in a combined analysis in a Scandinavian population ([@B20]). Rs540058 was reported to be associated with the severity of positive symptoms of SZ ([@B45]), and rs661575 was associated with visual learning and memory in Finnish families ([@B44]). The four SNPs are intronic and not in high linkage disequilibrium, so they are unlikely to have direct functional impacts on *RELN* and are unlikely to be co-inherited. However, SNPs in different functional areas may affect gene expression in different manners and have different effects on gene function ([@B28]). Moreover, up to 52% of all SNPs that were associated with disease were intronic SNPs ([@B6]; [@B28]). Hence, further studies on large samples are needed to verify the associations between the four SNPs and SZ, and rs362814 might be associated with SZ in an allele-dependent manner.

Rs2229864 is a synonymous mutation located in the 50th exon of the *RELN* gene. Rs2229864 was recognized to be detrimental in the screening process and was imbalanced in the allelic expression of *RELN* in SZ ([@B34]). Rs2535764 and rs262355 are both intronic SNPs and were slightly significant in the allelic association test only before the Bonferroni correction ([@B20]). Both rs262355 and rs2229864 failed to obtain definite positive results in subsequent studies ([@B25]). However, a weak association with P7 and haplotype consisting of rs2229864, rs2535764, and rs262355 withstood both the FDR and Bonferroni correction in the QTL analysis, which demonstrates that the relationship may be genuine rather than a false positive in this study. In addition, 4-SNP haplotypes consisting of the three SNPs and rs362626 or rs17157643 were associated with P7, G14 and S3, or P7 and S3, which all reflect the impulsive and dangerous behavior of SZ patients in PANSS. Both single item scores and scale scores were used as quantitative traits instead of synthesized scale scores in this study to deeply understand the relationships between the severity of clinical symptoms and genetic bases as well as the category of symptoms and genetics. Overall, we presumed that rs2229864, rs2535764, and rs262355 may be closely related to the risk for SZ patients, and subsequent studies with large samples will be especially necessary.

Another interesting phenomenon was that the AA/GG ratio of rs727708 seemingly had opposite trends in the SZ patients and controls, although a significant difference was not found in the allele or genotype association analyses. Both rs727708 and rs540058 were thought to be related to the severity of positive symptoms ([@B45]), so rs727708 may be related to both the susceptibility to and severity of SZ.

Both rs362691 and rs6465938 failed in single and multiple analyses. Rs362691 is a missense mutation located in the 22th exon of the *RELN* gene and can cause the Leu-Val amino acid change. Rs362691 had also been recognized as a detrimental mutation in the screening process. Researchers have found that rs362691 was not only associated with autism spectrum disorders (ASDs) ([@B43]) but might also take part in the influence of the *RELN* gene on the cognitive functions of healthy people ([@B3]). Haplotypes consisting of rs362691 rather than a SNP played roles in susceptibility to SZ in the Chinese Va population ([@B48]). A subtle but significant difference in the genotype frequency distribution of rs6465938 was found before multiple corrections. Notably, rs6465938 was not in HWE only in the patient samples. Moreover, rs6465938 showed a nominal association in a Scandinavian population ([@B20]). Therefore, negative results in this study should not be sufficient evidence to deny the possible associations between rs362691 or rs6465938 and SZ.

When subjects were divided by sex, none of these SNPs was found to be significantly associated with SZ in this study. Due to the small sample size, QTL analyses of different sexes were not performed. Many studies have demonstrated that males and females show different clinical factors, such as age of onset, treatment, cognitive function and clinical symptomatology ([@B39]; [@B33]; [@B50]; [@B40]), as well as genetic information ([@B37]; [@B27]). We agree with the notion that male SZ patients are different from female patients in terms of both clinical and genetic conditions. Our negative findings are mainly due to the small sample size and low statistical power, so studies with larger sample sizes would contribute to identifying sex differences in patients with SZ.

There are several possible explanations for the discrepancies between studies, such as genetic heterogeneity in distinct ethnic populations (Caucasian versus East Asian race, Han versus Va populations), the heterogeneity of SZ (subtypes and disease categories), population stratification, environmental exposure, cultures and diets ([@B25], [@B24]). Although we tried to reduce the effects of region and SZ subtype, the major limitation of the small sample size due to the rigorous standards still exists. The enrollment of patients principally from an outpatient service instead of an inpatient department may be another reason, as the overall PANSS scores may tend to be lower for outpatients than for hospitalized patients.

Conclusion
==========

In summary, the current investigation showed qualitative and quantitative trait associations between genetic variants in *RELN* and SZ in a southern Han Chinese population. Several SNPs showed significant associations with the pathogenesis of SZ and/or the severity of psychiatric symptoms principally in multi-SNP analyses. Considering the limitation of our work, further investigations of genetic susceptibility among larger samples and inpatients are required to elucidate the role of the *RELN* polymorphisms in the risk and sex difference of SZ as well as the severity of clinic symptoms in the future.
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DIGS

:   the Diagnostic Interview for Genetic Studies

DSM-IV

:   the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

FASTSNP

:   function analysis and selection tool for single nucleotide polymorphisms

FDR

:   false discovery rate

FIGS

:   the Familial Interview for Genetic Studies

GWAS

:   genome wide association study

HWE

:   Hardy-Weinberg equilibrium

MAF

:   minor allele frequency

OMIM

:   Online Mendelian Inheritance in Man

OR

:   odds ratios

PANSS

:   the positive and negative symptoms scale

QTL

:   quantitative trait loci

SIFT

:   Sorting Tolerant From Intolerant

SNPs

:   single nucleotide polymorphisms

SZ

:   schizophrenia

UTR

:   untranslated region.
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